WHO Drug Information - Volume 37, No. 4
13 October 2023
     | Publication
  Overview
The fourth issue of Volume 37, includes
Consultation Documents:
- IAEA/WHO Good manufacturing practices for in-house cold kits for radiopharmaceutical preparations
 - WHO Biowaiver project – prioritization exercise of Active Pharmaceutical Ingredients for cycle VI (2024) and preliminary results for cycle V (2023)
 - Fludeoxyglucose (18F) injection (Fludeoxyglucosi (18F) solution injectabilis)
 
ATC/DDD Classification:
- ATC/DDD Classification (Temporary)
 - ATC/DDD Classification (Final)
 
The fourth issue of Volume 37, concludes with:
 
International Nonproprietary Names (INN) Proposed List No. 130
WHO Team
         
                 
Access to Medicines and Health Products (MHP),                  
                 
INN and Classification of Medical Products (INN),                  
                 
Prequalification (PQT),                  
                 
                             Regulation and Prequalification (RPQ),                  
                 
Regulation and safety (REG)                 
         
        Editors
         World Health Organization
        Number of pages
         362
        Reference numbers
         ISBN: 978-92-4-008996-9